BiotechTube
Oculus Research

Oculus Research

Menlo Park, United States· Est.
oculusresearch.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Oculus Research is a private, US-based clinical research organization founded in 2014, operating as a site management organization (SMO) that conducts trials for external sponsors. The company has a strong track record in ophthalmology, having contributed to the development and FDA approval of nine treatments, including TYRVAYA, VEVYE, and MIEBO. Its business model is service-based, generating revenue from sponsors and CROs for patient recruitment and trial execution across a diverse range of therapeutic areas beyond eye care, such as vaccines, diabetes, and mental health.

OphthalmologyDry Eye DiseaseGlaucomaBlepharitisMyopiaNeurotrophic KeratopathyCataract SurgeryRetinal DiseaseConjunctivitisVaccinesObesityDiabetesWomen's HealthMental Health

Technology Platform

Operational platform for clinical trial execution, including patient recruitment, site management, and data collection services. Potential internal use of digital health/AI tools for optimization (not detailed).

Opportunities

Capitalize on strong ophthalmology track record to win more late-phase trials.
Expand into high-volume therapeutic areas like diabetes and obesity to diversify revenue.
Leverage accumulated clinical data and participant database to enhance recruitment efficiency and offer data-driven services to sponsors.

Risk Factors

Revenue is entirely dependent on winning competitive contracts from pharmaceutical sponsors.
Operational risks include patient recruitment delays and trial execution issues, which can damage client relationships.
Faces competition from large global CROs and other specialized site networks.

Competitive Landscape

Competes with large, full-service global CROs (e.g., IQVIA, ICON) and other specialized ophthalmology-focused SMOs and research sites. Differentiation is based on proven site-level efficiency, a strong track record in ophthalmology, and personalized service compared to larger, more bureaucratic competitors.

More companies in Digital Health & Biotech SaaS →More companies in United States →